Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Clinical Trial With Adoptive Transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation—A Second Report

6 Feb 2020

Abstract excerpt

BACKGROUND: Although the outcome of kidney transplantation (KTx) has improved, various adverse effects of immunosuppressants and chronic rejection aggravate the long-term prognosis of patients. Therefore, the induction of immune tolerance may be an effective therapeutic strategy. METHODS: A clinical trial aiming at immune tolerance induction was conducted in kidney transplant recipients from HLA mismatched living...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to Renal Transplantation Outcomes and Treatments
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33125206
DOI: 10.1097/tp.0000000000003149

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Clinical Trial With Adoptive Transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation—A Second ReportPMID 33125206Read ↗

T regulatory Cell-mediated Immunotherapy for Solid Organ Transplantation: A Clinical PerspectiveSemantic proximity Read ↗

Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and AutoimmunitySemantic proximity Read ↗

Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipients.Semantic proximity Read ↗

Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospectiveSemantic proximity Read ↗

Regulatory T cell therapy for Graft-versus-Host DiseaseSemantic proximity Read ↗

The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.Semantic proximity Read ↗

Peripheral biomarkers for individualizing immunosuppression in transplantation--regulatory T cells.Semantic proximity Read ↗

Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.Semantic proximity Read ↗

Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future PerspectivesSemantic proximity Read ↗

Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation.Semantic proximity Read ↗

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.Semantic proximity Read ↗

Advances on CD8+ Treg Cells and Their Potential in Transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.